In response to NA’s criticism regarding the delayed reimbursement listing of Kymriah, the government has expressed its difficulties as the decision was a result of an expert assessment.

Also, the government denied the claim that that insurance coverage is only being extended for mild diseases.

This was the response Health and Welfare Minister Deok Cheol Kwon gave to the claims that were made by NA member Jong Sung Lee at the NA Health and Welfare Committee’s audit of the Ministry of Health and Welfare that was held on the 7th.

Lee had previously pressed the government for the prompt listing of Kymriah, using Soliris in 2012 and Spinraza in 2019 as examples of how the go